Levodropropizine/Guaifenesin
左羟丙哌嗪/愈创甘油醚
Report date: 2025/07/25 17:51:25
Base Information
Drug NameLevodropropizine/Guaifenesin
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes LevodropropizineGuaifenesin
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHunan Jiudian Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesTaiyangsheng (Bozhou) Biomedical Technology Co LtdHunan Jiudian Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications +[4]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A